FindDrugs.org

Ro Weight Loss / GLP-1 Review

Weight Loss / GLP-1 · Reviewed Sep 14, 2026

7.54/10
Ro operator trust7.34/10See the full Ro brand review
Insurance-friendlyNo commitmentCash-pay

Our verdict

Ro is one of the most credible players in GLP-1 telehealth. It is licensed in all 50 states and dispenses genuine FDA-approved GLP-1s rather than leaning primarily on compounded semaglutide. That legitimacy, plus real insurance-navigation help, is its core strength. The catch is cost structure and service consistency: a $149/month membership is charged on top of medication, and recurring-billing, hidden-fee, and cancellation complaints keep its Trustpilot score around 3.7-3.8.

Price

from $149/mo · 4 plans

Check price

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

Key takeaways

  • All-50-state licensed telehealth dispensing brand-name FDA-approved GLP-1s
  • Membership ($39 first month, then $149/mo) is separate from medication (~$149-$299/mo); all-in ~$298/mo on compounded
  • Dedicated insurance concierge and prior-authorization support with a free GLP-1 insurance checker
  • Trustpilot ~3.7-3.8 with recurring billing/cancellation and customer-service complaints (BBB B)
  • Not individually named in the FDA compounded-GLP-1 warning-letter waves that hit many competitors

What is Ro Weight Loss / GLP-1?

Ro (formerly Roman) is a direct-to-consumer telehealth company operating since 2017, serving millions of patients across weight loss, sexual health, hair loss, fertility, and more. Its weight-loss offering is the Ro Body program.

Treatment options

Prices as of Sep 14, 2026 — verify current on the brand's site.

Getting started with Ro

  1. Complete the online health questionnaire (results within ~2 days)
  2. A US-licensed provider reviews eligibility and contraindications
  3. If prescribed, Ro verifies insurance and assists with prior authorization, or ships cash-pay medication
  4. Cash-pay medication can arrive in under a week; insurance path typically ~2-3 weeks
  5. Ongoing provider check-ins and support (how dose changes are managed is not restated here — see gaps)

Methodology scorecard

Scored on Sep 14, 2026 under methodology v6

7.54/10

Coverage: Checked against 6 recorded withdrawals. Marking matches the wording each withdrawal was recorded in, so the same claim stated differently is not marked.

One factor could not be established: Legitimacy & Accreditation

We could not establish this from a third-party record. What we searched: accreditation and licensing bodies — LegitScript, NABP including its .pharmacy verification, and URAC — state licensing registries, and the provider’s own corporate disclosures. On LegitScript we read the provider’s own website and never LegitScript’s register: their terms do not permit automated queries to it, so a LegitScript-issued seal found on a provider’s pages establishes that the seal was displayed there on that date, and not that a certification is current. No register, federal or otherwise, answers whether an operation is licensed in every state it ships to; of the six government hosts we read on 2026-08-25, three do not permit us. This is a statement about what we were able to verify, never a finding that the provider lacks accreditation. Where a provider states its own licensure or displays its own seal, that is recorded as the provider’s own claim and lifts no subscore by itself.

Pricing & cancellation

Check price

All-in price

from $149/mo · 4 options

Cost structure
Month-to-month membership with optional prepaid annual plan.
Insurance vs. cash
Cash-pay
Deal structure
Cancellation
Cancel anytime to stop future renewals; membership fee non-refundable once billed for the current cycle.
Forced subscription
Not required

Pros & cons

Pros

  • Genuine clinician review with real prescriber oversight
  • Large, well-funded, high-momentum operator
  • Broad treatment catalog under one account
  • Discreet, free shipping

Cons

  • Membership billed separately from medication cost
  • Pricing frequently gated behind the intake quiz
  • Compounding pharmacies not named in any category
  • Heavy promotion of non-FDA-approved compounded formulations

Safety

Talk to a licensed clinician

Ro screens with an online health questionnaire reviewed by a US-licensed provider, and applies standard eligibility (BMI over 30, or over 27 with a weight-related condition). GLP-1s carry a boxed warning for thyroid C-cell tumors and are contraindicated in people with a personal or family history of MTC or MEN 2, and in pregnancy. Common side effects are gastrointestinal, with rarer risks of pancreatitis and gallbladder problems.

Common side effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal pain
  • Injection-site reactions
  • Rare: pancreatitis
  • Rare: gallbladder problems

Who should not take it

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • Pregnancy or planning pregnancy
  • History of pancreatitis (use with caution)
  • Known hypersensitivity to semaglutide/tirzepatide

The bottom line

Ro is a top-tier-legitimacy, upper-middle-overall GLP-1 telehealth option: genuine FDA-approved medication, real insurance navigation, and enormous scale, held back by a stacked membership-plus-medication cost and uneven billing/customer-service experiences.

Check price

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

See how Ro ranks among GLP-1 providers

What changed & why

This brand's own history — every re-review and methodology recompute, logged. Rankings change when the evidence or the rules change, never for payment. See the site-wide methodology ledger for version history.

  1. Sep 14, 2026Methodologymethodology v67.467.54

    We changed how this score is calculated, and Weight Management / GLP-1 score moved from 7.46 to 7.54. 1 of the factors behind it moved. How we score.

    1 factor withdrawn — assessed coverage fell 12 → 11. Part of any score movement here reflects evidence we retracted, not a change in the brand.

  2. Aug 23, 2026Methodologymethodology v37.657.46

    We changed how this score is calculated, and Weight Management / GLP-1 score moved from 7.65 to 7.46. 3 of the factors behind it moved. How we score.

    3 factors withdrawn — assessed coverage fell 15 → 12. Part of any score movement here reflects evidence we retracted, not a change in the brand.

  3. Jul 24, 2026Re-review8.507.65

    Weight Management / GLP-1 score moved from 8.50 to 7.65 after a fresh review of the evidence. 15 of the factors behind it moved.

    Whether this score rests on more or less evidence than the previous one is not recorded — the earlier score did not store how many factors it assessed.

Frequently asked questions

Does Ro's membership fee include the medication?

No. The Ro Body membership ($39 the first month, then $149/month) is charged separately from the GLP-1 medication, which ranges from about $149/month to about $299/month. Insurance may lower the medication cost.

Does Ro prescribe real brand-name Wegovy and Zepbound?

Yes. Ro dispenses brand-name FDA-approved Wegovy, Zepbound, and Ozempic sourced through official channels, in addition to offering compounded semaglutide in some cases.

Can I cancel Ro anytime and get a refund?

You can cancel to stop future renewals, but the membership fee is non-refundable once billed and prescription medication sales are final. If medication is never prescribed, Ro says you are refunded and not enrolled.

Will Ro help with insurance?

Yes. Ro offers a dedicated insurance concierge, prior-authorization assistance, and a free GLP-1 insurance checker; insurance processing typically takes about 2-3 weeks.

Work at Ro?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Scored on 11 of 14 factors · 7 sources cited

Brand site

Regulatory

Reviews

What we couldn't verify

  • Fulfilling pharmacy and 503A/503B compounding pharmacy are not identified in any record we could retrieve.
  • Privacy/security posture rests on standard HIPAA-covered-telehealth assumptions; no independent audit trail was retrievable.
  • Individual prescribing clinician identities were not found in any record we could retrieve.
  • Withdrawn — Ro is LegitScript-certified. WITHDRAWN. legitscript.com/websites/ro.co/ returns HTTP 200 but serves a reCAPTCHA form shell with no certification status and no mention of ro.co (retrieved 2026-08-13); api.legitscript.com returns 403, seal-ID routes 404, the sitemap is empty, and ro.co's own badge is an unlinked image. The prior citation was the legitscript.com HOMEPAGE, which states nothing about Ro. Retrieval-failed, not disproved — the same test fridays failed with a 403.
  • Withdrawn — Ro funding/revenue figures (raised, valuation, revenue, projections). WITHDRAWN. Sourced only to sacra.com, a market-data aggregator that neither originates nor audits the figures. Ro is private; no filing or audited record is retrievable.
  • Withdrawn — Ro is a "preferred distribution partner" of Novo Nordisk and Eli Lilly. WITHDRAWN. Cited to press/affiliate only. Not re-pointable: novocare.com (200) names Ro on no fetchable page and lillydirect.lilly.com returns HTTP 403 (retrieval-failed). Ro's own claim to source through those channels is retained as company-attested.
  • Withdrawn — Ro surfaces contraindication warnings during intake. WITHDRAWN. A safety-behaviour claim resting on the company's own page; no label or registry record can establish what a telehealth intake surfaces.
  • Withdrawn — Ro operates provider-managed dose titration with starter-dose offerings and ongoing check-ins. WITHDRAWN and the factor EXCLUDED. A dosing claim requires a label or registry record; none describes a telehealth provider's titration practice.
  • Withdrawn — Ro "discloses membership terms, contraindications, and expected outcomes with cited studies". WITHDRAWN. A favourable disclosure-quality claim resting solely on Ro's own page; a label records what the contraindications are, not that Ro surfaces them, so it is not re-pointable (punch list § G9).
Last reviewed Sep 14, 2026 · methodology v6View the ledger

Top pick

Ro 7.54/10